Manatuck Hill Partners’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Manatuck Hill Partners’s Portfolio AST.WS Stock Details AST.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-75,000	Closed	-$38K	–	107
2017 Q2	$38K	Hold	75,000	–	–	0.02%	81
2017 Q1	$32K	Hold	75,000	–	–	0.01%	87
2016 Q4	$41K	Hold	75,000	–	–	0.02%	84
2016 Q3	$39K	Buy	+75,000	New	+$20.5K	0.02%	92

Manatuck Hill Partners's AST.WS Position: Q3 2017 in Review

Manatuck Hill Partners sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 75,000 shares — an estimated $38K sold.

Manatuck Hill Partners first reported a position in AST.WS in Q3 2016 and held it in 4 quarters. The position peaked at $41K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

Manatuck Hill Partners reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
Manatuck Hill Partners sold 75,000 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $38K.
Manatuck Hill Partners first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q3 2016 and held it in 4 quarters.
Manatuck Hill Partners's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $41K in Q4 2016.
3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Manatuck Hill Partners's 13F filing for Q3 2017, filed 14 Nov 2017.